Citations

Showing 10 of 108094 citations.

In Vitro Activity of Imipenem-Relebactam and Ceftolozane-Tazobactam against Resistant Gram-Negative Bacilli
Schmidt-Malan, Suzannah M., Mishra, Avisya J., Mushtaq, Ammara , Brinkman, Cassandra L., Patel, Robin , Patel, Robin

Mayo Clinic

Antimicrobial Agents and Chemotherapy | May 15, 2018 | Volume: 62 | Issue: 8 | Pages: No page available

10.1128/aac.00533-18 | PMID 29760145 Get It

Understanding which antimicrobial agents are likely to be active against Gram-negative bacilli can guide selection of antimicrobials for empirical therapy as mechanistic rapid diagnostics are adopted. In this study, we determined the MICs of a novel β-lactam–β-lactamase inhibitor combination, imipenem-relebactam, along with ceftolozane-tazobactam, imipenem, ertapenem, meropenem, ceftriaxone, and cefepime, against 282 drug-resistant isolates of Gram-negative bacilli.
“Mirror, Mirror on the Wall”… Pediatric liver transplantation in the case of situs inversus totalis with a disrupted inferior vena cava
Edgerton, Colston , Gross, Megan, Kasi, Nagraj, Hewitt, Winston R. , Edmondson, Sara, Rohan, Vinayak , Nadig, Satish N. , Edgerton, Colston A , Hewitt, Winston, Gross, Megan

Mayo Clinic

Pediatric Transplantation | May 15, 2018 | Volume: 22 | Issue: 5 | Pages: No page available

10.1111/petr.13218 | PMID 29761937 Get It

Abstract We present the unique case of a 15‐month‐old male born with biliary atresia and situs inversus totalis and disrupted inferior vena cava who underwent a successful liver transplantation. The patient had previously undergone a failed Kasai procedure and presented with persistent hyperbilirubinemia. The patient was transplanted with a left lateral segment donor having standard arterial anatomy. Technical considerations included identifying completely replaced arterial anatomy in the recipient from the superior mesenteric artery and creating a branch patch between the gastroduodenal artery and HA, anastomosing the donor left hepatic vein to confluences of the donor left, middle, and right hepatic veins, using a “lazy‐S” configuration of portal vein anastomosis, and suspending the allograft to the abdominal wall. Post‐operatively, his liver function tests and total bilirubin normalized and he progressed to tolerating an oral diet with tube‐feed supplementation.
The Caenorhabditis elegans Ortholog of TDP-43 Regulates the Chromatin Localization of the Heterochromatin Protein 1 Homolog HPL-2
Saldi, Tassa , Gonzales, Patrick , Garrido‐Lecca, Alfonso, Dostal, Vishantie , Roberts, Christine M. , Petrucelli, Leonard , Link, Christopher D. , Saldi, Tassa K

Mayo Clinic

Molecular and Cellular Biology | May 15, 2018 | Volume: 38 | Issue: 15 | Pages: No page available

10.1128/mcb.00668-17 | PMID 29760282 Get It

A New Strategy to Control and Eradicate “Undruggable” Oncogenic K-RAS-Driven Pancreatic Cancer: Molecular Insights and Core Principles Learned from Developmental and Evolutionary Biology
Sciver, Robert E. Van , Lee, Michael , Lafever, Alex, Svyatova, Elizaveta , Kanda, Kevin, Collier, Amber L. , Reesema, LL Siewertsz van, Tang-Tan, Angela M., Zheleva, Vasilena, Bwayi, Monicah, Bian, Minglei, Schmidt, Rebecca L., Matrisian, Lynn M. , Petersen, Gloria M. , Van Sciver, Robert E , Matrisian, Lynn M , Lee, Caroline Guat Lay , Tang, Amy

Mayo Clinic

Cancers | May 15, 2018 | Volume: 10 | Issue: 5 | Pages: 142

10.3390/cancers10050142 | PMID 29757973 Get It

Oncogenic K-RAS mutations are found in virtually all pancreatic cancers, making K-RAS one of the most targeted oncoproteins for drug development in cancer therapies. Despite intense research efforts over the past three decades, oncogenic K-RAS has remained largely “undruggable”. Rather than targeting an upstream component of the RAS signaling pathway (i.e., EGFR/HER2) and/or the midstream effector kinases (i.e., RAF/MEK/ERK/PI3K/mTOR), we propose an alternative strategy to control oncogenic K-RAS signal by targeting its most downstream signaling module, Seven-In-Absentia Homolog (SIAH). SIAH E3 ligase controls the signal output of oncogenic K-RAS hyperactivation that drives unchecked cell proliferation, uncontrolled tumor growth, and rapid cancer cell dissemination in human pancreatic cancer. Therefore, SIAH is an ideal therapeutic target as it is an extraordinarily conserved downstream signaling gatekeeper indispensable for proper RAS signaling. Guided by molecular insights and core principles obtained from developmental and evolutionary biology, we propose an anti-SIAH-centered anti-K-RAS strategy as a logical and alternative anticancer strategy to dampen uncontrolled K-RAS hyperactivation and halt tumor growth and metastasis in pancreatic cancer. The clinical utility of developing SIAH as both a tumor-specific and therapy-responsive biomarker, as well as a viable anti-K-RAS drug target, is logically simple and conceptually innovative. SIAH clearly constitutes a major tumor vulnerability and K-RAS signaling bottleneck in pancreatic ductal adenocarcinoma (PDAC). Given the high degree of evolutionary conservation in the K-RAS/SIAH signaling pathway, an anti-SIAH-based anti-PDAC therapy will synergize with covalent K-RAS inhibitors and direct K-RAS targeted initiatives to control and eradicate pancreatic cancer in the future.
Association between an individual housing-based socioeconomic index and inconsistent self-reporting of health conditions: a prospective cohort study in the Mayo Clinic Biobank
Ryu, Euijung , Juhn, Young J. , Hathcock, Matthew , Yost, Kathleen J. , Hathcock, Matthew A, Takahashi, Paul Y. , Olson, Janet E. , Wi, Chung‐Il , Cerhan, James R.

Mayo Clinic

BMJ Open | May 15, 2018 | Volume: 8 | Issue: 5 | Pages: e020054

10.1136/bmjopen-2017-020054 | PMID 29764878 Get It

Objective Using surveys to collect self-reported information on health and disease is commonly used in clinical practice and epidemiological research. However, the inconsistency of self-reported information collected longitudinally in repeated surveys is not well investigated. We aimed to investigate whether a socioeconomic status based on current housing characteristics, HOUsing-based SocioEconomic Status (HOUSES) index linking current address information to real estate property data, is associated with inconsistent self-reporting. Study setting and participants We performed a prospective cohort study using the Mayo Clinic Biobank (MCB) participants who resided in Olmsted County, Minnesota, USA, at the time of enrolment between 2009 and 2013, and were invited for a 4-year follow-up survey (n=11 717). Primary and secondary outcome measures Using repeated survey data collected at the baseline and 4 years later, the primary outcome was the inconsistency in survey results when reporting prevalent diseases, defined by reporting to have ‘ever’ been diagnosed with a given disease in the baseline survey but reported ‘never’ in the follow-up survey. Secondary outcome was the response rate for the 4-year follow-up survey. Results Among the MCB participants invited for the 4-year follow-up survey, 8508/11 717 (73%) responded to the survey. Forty-three per cent had at least one inconsistent self-reported disease. Lower HOUSES was associated with higher inconsistency rates, and the association remained significant after pertinent characteristics such as age and perceived general health (OR=1.46; 95% CI 1.17 to 1.84 for the lowest compared with the highest HOUSES decile). HOUSES was also associated with lower response rate for the follow-up survey (56% vs 77% for the lowest vs the highest HOUSES decile). Conclusion This study demonstrates the importance of using the HOUSES index that reflects current SES when using self-reporting through repeated surveys, as the HOUSES index at baseline survey was inversely associated with inconsistent self-report and the response rate for the follow-up survey.
Spindle cell rhabdomyosarcoma of bone with FUS–TFCP2 fusion: confirmation of a very recently described rhabdomyosarcoma subtype
Dashti, Nooshi K, Wehrs, Rebecca N., Thomas, Brittany C. , Nair, Asha, Davila, Jaime , Buckner, Jan C. , Martinez, Anthony P, Sukov, William R. , Halling, Kevin C. , Howe, Benjamin M. , Folpe, Andrew L. , Davila, Jaime I , Dashti, Nooshin K. , Martinez, Anthony P

Mayo Clinic

Histopathology | May 14, 2018 | Volume: 73 | Issue: 3 | Pages: 514-520

10.1111/his.13649 | PMID 29758589 Get It

AimsRhabdomyosarcomas of bone are extremely rare, with fewer than 10 reported cases. A very rare subtype of spindle cell/sclerosing rhabdomyosarcoma harbouring a FUS–TFCP2 fusion and involving both soft tissue and bone locations has been reported very recently. We report only the fourth case of this unusual, clinically aggressive rhabdomyosarcoma.Material and resultsA previously well 72‐year‐old male presented with a destructive lesion of the mandible. Morphological and immunohistochemical study of a needle biopsy and the subsequent resection showed a spindle cell rhabdomyosarcoma. RNA‐seq, RT–PCR and FISH confirmed the presence of the FUS–TFCP2 fusion.ConclusionsSpindle cell rhabdomyosarcomas carrying the FUS–TFCP2 fusion are very rare rhabdomyosarcoma variants with osseous predilection. The classification and differential diagnosis of this unusual molecular variant of spindle cell/sclerosing rhabdomyosarcoma are discussed.
US of Right Upper Quadrant Pain in the Emergency Department: Diagnosing beyond Gallbladder and Biliary Disease
Joshi, Gayatri , Crawford, Kevin A., Herr, Keith D. , Dahiya, Nirvikar , Menias, Christine O. , Hanna, Tarek N, Hanna, Tarek N

Mayo Clinic

RadioGraphics | May 14, 2018 | Volume: 38 | Issue: 3 | Pages: 766-793

10.1148/rg.2018170149 | PMID 29757718 Get It

Lung-Resident Mesenchymal Stromal Cells Reveal Transcriptional Dynamics of Lung Development in Preterm Infants
Spadafora, Ruggero , Lu, Junjie , Khetani, Radhika S. , Iberg, Aimee, Shi, Yang , Lerou, Paul H. , Zhang, Cheng , Li, Hu

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 14, 2018 | Volume: 198 | Issue: 7 | Pages: 961-964

10.1164/rccm.201801-0024le | PMID 29757681 Get It

Detectable High-Sensitivity Cardiac Troponin within the Population Reference Interval Conveys High 5-Year Cardiovascular Risk: An Observational Study
Than, Martin , Aldous, Sally, Troughton, Richard W. , Pemberton, Christopher J, Richards, Mark , Frampton, Christopher , Florkowski, Christopher M , Bailey, Samantha, Young, Joanna M. , Cullen, Louise , Greenslade, Jaimi , Parsonage, William , Jaffe, Allan S. , Pickering, John W. , Cullen, Louise , Pemberton, Christopher J, George, Peter Myles , Everett, Brendan M. , Peacock, William Frank , Jaffe, Allan S. , Troughton, Richard W , Richards, Arthur M , Than, Martin

Mayo Clinic

Clinical Chemistry | May 14, 2018 | Volume: 64 | Issue: 7 | Pages: 1044-1053

10.1373/clinchem.2017.285700 | PMID 29760219 Get It

AbstractBACKGROUNDIncreased cardiac troponin I or T detected by high-sensitivity assays (hs-cTnI or hs-cTnT) confers an increased risk of adverse prognosis. We determined whether patients presenting with putatively normal, detectable cTn concentrations [> limit of detection and < upper reference limit (URL)] have increased risk of major adverse cardiovascular events (MACE) or all-cause mortality.METHODSA prospective 5-year follow-up of patients recruited in the emergency department with possible acute coronary syndrome (ACS) and cTn concentrations measured with hs-cTnI (Abbott) and hs-cTnT (Roche) assays. Cox regression models were generated with adjustment for covariates in those without MACE on presentation. Hazard ratios (HRs) for hs-cTn were calculated relative to the HRs at the median concentration.RESULTSOf 1113 patients, 836 were without presentation MACE. Of these, 138 incurred a MACE and 169 died during a median 5.8-year follow-up. HRs for MACE at the URLs were 2.3 (95% CI, 1.7–3.2) for hs-cTnI and 1.8 (95% CI, 1.3–2.4) for hs-cTnT. Corresponding HRs for mortality were 1.7 (95% CI, 1.2–2.2) for hs-cTnI and 2.3 (95 % CI, 1.7–3.1) for hs-cTnT. The HR for MACE increased with increasing hs-cTn concentration similarly for both assays, but the HR for mortality increased at approximately twice the rate for hs-cTnT than hs-cTnI. Patients with hs-cTnI ≥10 ng/L or hs-cTnT ≥16 ng/L had the same percentage of MACE at 5-year follow-up (33%) as patients with presentation MACE.CONCLUSIONSMany patients with ACS ruled out and putatively normal but detectable hs-cTnI concentrations are at similar long-term risk as those with MACE. hs-cTnT concentrations are more strongly associated with 5-year mortality than hs-cTnI.
Exhaled Nitric Oxide Changes During Acclimatization to High Altitude: A Descriptive Study
Summerfield, Douglas T. , Coffman, Kirsten E. , Taylor, Bryan J. , Issa, Amine, Johnson, Bruce D., Issa, Amine N, Taylor, Bryan J

Mayo Clinic

High Altitude Medicine & Biology | May 14, 2018 | Volume: 19 | Issue: 3 | Pages: 215-220

10.1089/ham.2017.0109 | PMID 29757001 Get It